SPOTFIRE Sore Throat (ST) Study
NCT06713642 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2026-03-23
Summary
The purpose of this study is to evaluate where urgent care (UC) clinicians see the most benefit for a novel, point of care pharyngitis test, SPOTFIRE ST, and describe its performance, potential clinical utility, and satisfaction of providers and patients with this novel test. Up to 200 participants will be on study for up to approximately 25 minutes.
Conditions
- Pharyngitis, Infective
Interventions
- DEVICE
-
SPOTFIRE ST System
Polymerase chain reaction (PCR) test that identifies up to 13 different viral and bacterial pathogens in about 20 Minutes
Sponsors & Collaborators
-
BioMérieux
collaborator INDUSTRY -
University of Wisconsin, Madison
lead OTHER
Principal Investigators
-
Alexander Lepak, MD · UW School of Medicine and Public Health
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-12-02
- Primary Completion
- 2025-03-31
- Completion
- 2025-03-31
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)
NCT03489629 ·Status: COMPLETED ·Phase: PHASE2
-
Performance of Ellume·Lab Group A Strep Test Versus Culture for the Rapid Detection of Group A Streptococcus in Patients With Acute Pharyngitis.
NCT03171350 ·Status: COMPLETED ·Phase: NA
-
GRoup A StrePtococcus
NCT01558804 ·Status: RECRUITING
-
Performance of Ellume·Lab Group A Strep Test Versus Culture for the Rapid Detection of Group A Streptococcus in Participants With Acute Pharyngitis
NCT03693495 ·Status: WITHDRAWN ·Phase: NA
-
A Novel Approach to Methicillin-resistant Staphylococcus Aureus (MRSA) Screening of Colonized Patients
NCT01234831 ·Status: COMPLETED ·Phase: NA
-
Safety and Tolerability Study of Antimicrobial TheraGauze for Skin Abscess
NCT02334384 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Methicillin-sensitive and Methicillin-resistant Staphylococcus Aureus (MSSA/MRSA) - Point-of-care-testing (POCT) in Clinical Decision Making
NCT03220386 ·Status: UNKNOWN ·Phase: NA
-
Human Immunity Against Staphylococcus Aureus Skin Infection
NCT02262819 ·Status: COMPLETED ·Phase: PHASE1
-
Antimicrobial Stewardship Through MRSA Diagnosis in Emergency Department (ED) Patients With Abscesses
NCT01523899 ·Status: COMPLETED ·Phase: NA
-
Nasal Swab Study to Explore the Nasal Microbia
NCT02535442 ·Status: COMPLETED
-
TMC207-TiDP13-C208: Anti-bacterial Activity, Safety, and Tolerability of TMC207 in Participants With Multi-drug Resistant Mycobacterium Tuberculosis (MDR-TB).
NCT00449644 ·Status: COMPLETED ·Phase: PHASE2
-
Periscope Phase C Bordetella Pertussis Human Challenge Study With Delayed Antibiotic Therapy for 6 Weeks
NCT05847322 ·Status: RECRUITING ·Phase: NA
-
Study of the Performance of the KeyPath MRSA/MSSA Blood Culture Test - BTA
NCT01640886 ·Status: TERMINATED
-
Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP)
NCT01594827 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Antibiotic Delivery Via Bio-absorbable Sponge
NCT01222832 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess the Efficacy and Safety of STI-1558 in Adult Subjects With Mild or Moderate (COVID-19)
NCT05716425 ·Status: COMPLETED ·Phase: PHASE3
-
Initial and Chronic Methicillin Resistant Staphylococcus Aureus (MRSA) Infection in Cystic Fibrosis (CF)
NCT02684422 ·Status: COMPLETED
-
Safety & Efficacy of True Human Antibody, 514G3, in Staphylococcus Aureus Bacteremia Hospitalized Subjects.
NCT02357966 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
INSPIRE Trial for Skin and Soft Tissue Infections
NCT05423756 ·Status: COMPLETED ·Phase: NA
-
Staph Household Intervention for Eradication (SHINE)
NCT02572791 ·Status: COMPLETED ·Phase: PHASE4
-
To Evaluate the Safety, Tolerability, and Efficacy of TMC207 as Part of an Individualized Multi-drug Resistant Tuberculosis (MDR-TB) Treatment Regimen in Participants With Sputum Smear-positive Pulmonary MDR-TB.
NCT00910871 ·Status: COMPLETED ·Phase: PHASE2
-
Feasibility Study of Phototherapy System to Treat H Pylori
NCT00306280 ·Status: UNKNOWN ·Phase: NA
-
Early Infectious Disease Consultations in Staphylococcus Aureus Bacteremia
NCT00622882 ·Status: UNKNOWN ·Phase: NA
-
Safety, Tolerability, and Immunogenicity of a Single Dose of Merck 0657nI Staphylococcus Aureus Vaccine With or Without Merck Aluminum Adjuvant (V710-002)
NCT01324440 ·Status: COMPLETED ·Phase: PHASE1
-
Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)
NCT01349192 ·Status: TERMINATED ·Phase: PHASE2